Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SPRY4 |
| Upstream (Parents) |
|---|
| (<<) ADCY6 → SPRY4 |
| (<<) CMTM7 → SPRY4 |
| (<<) CREB3L1 → SPRY4 |
| (<<) CYR61 → SPRY4 |
| (<<) DAZAP2 → SPRY4 |
| (<<) DUSP6 → SPRY4 |
| (<<) EDNRA → SPRY4 |
| (<<) ID1 → SPRY4 |
| (<<) ITGA5 → SPRY4 |
| (<<) ITGB1 → SPRY4 |
| (<<) PLAU → SPRY4 |
| (<<) PPIB → SPRY4 |
| (<<) PPP1R3B → SPRY4 |
| (<<) PTK7 → SPRY4 |
| (<<) RAB5B → SPRY4 |
| (<<) RHOB → SPRY4 |
| (<<) THY1 → SPRY4 |
| (<<) TIMP3 → SPRY4 |
| (<<) TMEM45B → SPRY4 |
| (<<) ZBED2 → SPRY4 |
| Downstream (Children) |
|---|
| SPRY4 → ALOX15B (>>) |
| SPRY4 → CHODL (>>) |
| SPRY4 → CITED4 (>>) |
| SPRY4 → DUSP10 (>>) |
| SPRY4 → E2F2 (>>) |
| SPRY4 → ELF3 (>>) |
| SPRY4 → ELF4 (>>) |
| SPRY4 → ELF5 (>>) |
| SPRY4 → FAM83A (>>) |
| SPRY4 → HMGCR (>>) |
| SPRY4 → IER3 (>>) |
| SPRY4 → IRAK1 (>>) |
| SPRY4 → IRX2 (>>) |
| SPRY4 → KLHL7 (>>) |
| SPRY4 → KREMEN1 (>>) |
| SPRY4 → MAN2A2 (>>) |
| SPRY4 → NEDD4 (>>) |
| SPRY4 → PARP10 (>>) |
| SPRY4 → PCSK7 (>>) |
| SPRY4 → SIN3A (>>) |
| SPRY4 → TNC (>>) |
